Jazz Pharmaceuticals Plc
(NASDAQ : JAZZ)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc. -2.71%28.4014.1%$167.11m
AMRNAmarin Corp. Plc -2.60%20.221.7%$161.85m
AXSMAxsome Therapeutics, Inc. -2.92%85.201.9%$90.60m
BHCBausch Health Cos., Inc. -2.71%28.400.0%$84.60m
GWPHGW Pharmaceuticals Plc -1.20%114.516.2%$73.62m
JAZZJazz Pharmaceuticals Plc -2.25%145.742.3%$63.95m
PRGOPerrigo Co. Plc -1.24%58.746.8%$63.73m
ICPTIntercept Pharmaceuticals, Inc. -3.02%96.6516.9%$61.51m
SAVACassava Sciences, Inc. -7.18%7.180.0%$60.84m
SAGESAGE Therapeutics, Inc. -3.46%68.028.6%$58.61m
HZNPHorizon Therapeutics Plc -2.83%36.066.6%$56.41m
MNKMallinckrodt Plc -7.68%5.1720.9%$43.68m
ICLRICON plc 0.09%174.954.2%$39.55m
CTLTCatalent, Inc. 0.05%61.602.4%$37.97m
UTHRUnited Therapeutics Corp. -1.70%89.3314.3%$34.80m

Company Profile

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Dublin, Ireland.